StonvexLoading…
StonvexStonvexStonvexCore line items from VYX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-05 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $526.91M | $606.00M | $2.69B | $1.97B | $1.28B |
Operating Income | Not available | $-19.00M | $26.00M | $9.00M | $-6.00M |
Net Income | Not available | $-5.00M | $62.00M | $-36.00M | $-17.00M |
EPS (Diluted) | $0.15 | $-0.06 | $0.30 | $-0.34 | $-0.18 |
Total Assets | Not available | $3.92B | $3.92B | $4.00B | $3.98B |
Total Liabilities | Not available | $2.79B | $2.77B | $2.88B | $2.84B |
Cash & Equivalents | Not available | $232.00M | $231.00M | $282.00M | $276.00M |
Free Cash Flow OCF − CapEx | Not available | $6.00M | $-375.00M | $-289.00M | $-299.00M |
Shares Outstanding | Not available | 138.50M | 138.10M | 138.30M | 137.90M |